Plooster Matthew R 4
4 · KEMPHARM, INC · Filed Dec 1, 2021
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Plooster Matthew R
Director
Transactions
- Award
Common Stock
2021-12-01$8.44/sh+2,500$21,100→ 2,500 total
Holdings
- 1,532
Common Stock
- 69(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Held jointly with spouse.